1. Change in antibiotic regimen for emerging multidrug resistance in nosocomial ascitic fluid infection

   • Seema Alam

   Editorial 21 November 2019 Pages: 1 - 4

   

2. Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease

   • Yong-ho Lee
   • Seung Up Kim

   Editorial 21 November 2019 Pages: 5 - 7

3. New drugs for NAFLD: lessons from basic models to the clinic

   • Katharina C. Reimer
   • Alexander Wree
   • Frank Tacke

   Review Article 04 December 2019 Pages: 8 - 23

   

4. Antimicrobial resistance in chronic liver disease

   • Vishal C. Patel
   • Roger Williams

   Review Article Open access 03 December 2019 Pages: 24 - 34

   

5. Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

   • Lung-Yi Mak
   • Wai-Kay Seto
   • Man-Fung Yuen

   Review Article 19 November 2019 Pages: 35 - 46

   

6. Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure

   • Guojun Shen
   • Shuilin Sun
   • Xiaodong Gong

   Original Article 23 December 2019 Pages: 47 - 56

   

7. Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficacious

   • Mark D. Muthiah
   • En Ying Tan
   • Boon Leng Lim

   Original Article 10 January 2020 Pages: 57 - 69

   

8. Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging

   • Sunyoung Lee
   • Myeong-Jin Kim
   • Donald G. Mitchell

   Original Article 04 December 2019 Pages: 70 - 79

   

9. Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma

   • Jing Liao
   • Dan-Ni Zeng
   • Yan Wu

   Original Article 04 December 2019 Pages: 80 - 95

   

10. Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology

    • Ahmed Musa Hago Bakheet
    • Chang Zhao
    • Chun-Kui Shao

    Original Article 12 December 2019 Pages: 96 - 104

    

11. Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis

    • Min Li
    • Tingting Lv
    • Jidong Jia

    Original Article 03 January 2020 Pages: 105 - 114

    

12. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis

    • Changzhou Cai
    • Xin Song
    • Chaohui Yu

    Original Article Open access 09 July 2019 Pages: 115 - 126

    

13. Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease

    • Gema Gómez-Mariano
    • Nerea Matamala
    • Beatriz Martínez-Delgado

    Original Article Open access 13 December 2019 Pages: 127 - 137

    

14. Ascitic fluid infection in children with liver disease: time to change empirical antibiotic policy

    • Sumit Kumar Singh
    • Ujjal Poddar
    • Surender Kumar Yachha

    Original Article 09 July 2019 Pages: 138 - 144

15. TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF-κB/NLRP3 inflammasome signaling pathways

    • Jing Zhao
    • Ming Han
    • Jun Cheng

    Original Article 22 November 2019 Pages: 145 - 160